Amicus Therapeutics Aktie
8,40
EUR
+0,20
EUR
+2,44
%
9,45
USD
-0,28
USD
-2,88
%
Werbung
Amicus Therapeutics Aktie Analyse
| 17.06.19 | Amicus Therapeutics Buy | H.C. Wainwright & Co. | |
| 05.06.19 | Amicus Therapeutics Overweight | Cantor Fitzgerald | |
| 30.01.19 | Amicus Therapeutics Overweight | Cantor Fitzgerald | |
| 17.08.18 | Amicus Therapeutics Neutral | Chardan Capital Markets | |
| 13.09.17 | Amicus Therapeutics Buy | Chardan Capital Markets | |
| 10.08.17 | Amicus Therapeutics Buy | Chardan Capital Markets | |
| 24.01.17 | Amicus Therapeutics Outperform | Robert W. Baird & Co. Incorporated | |
| 14.04.16 | Amicus Therapeutics Neutral | Robert W. Baird & Co. Incorporated | |
|
Werbung
|
|||
| 12.04.16 | Amicus Therapeutics Buy | Chardan Capital Markets | |
| 05.10.15 | Amicus Therapeutics Hold | Lake Street | |
| 16.09.15 | Amicus Therapeutics Neutral | Chardan Capital Markets | |
| 16.06.15 | Amicus Therapeutics Buy | Chardan Capital Markets | |
| 29.05.15 | Amicus Therapeutics Buy | Chardan Capital Markets | |
| 12.02.08 | Amicus Therapeutics | Global Insider Investing | |
Werbung
Werbung